Medical News

RSS

Health care TV ads top $100 million

"Medical providers, businesses and other groups battling over a health care overhaul have spent more than $100 million this year on television advertising — an enormous sum that highlights the stakes involved," according to the Campaign Media Analysis Group, The Associated Press/The Boston Globe reports.

1 Oct 2009

Stockholders approve BioSante Pharmaceuticals–Cell Genesys merger

BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., today announced that BioSante stockholders have approved the merger between the two companies with BioSante as the surviving company.

1 Oct 2009

Also in global health news: Tanzania's development initiatives; disease surveillance in West Africa; water, sanitation in Kenya, Malawi; doctor fights Lassa fever

House Speaker Nancy Pelosi, D-Calif., on Tuesday commended Tanazanian President Jakaya Kikwete on the country's utilization of U.S. aid money and vowed her support for the country's future development projects, during a meeting in Washington, D.C., the Zimbabwean reports. "Pelosi hailed President Kikwete and his government for the commitment demonstrated by the campaigns against HIV/AIDS, malaria and TB and implementation of MCC programmes," the newspaper writes (Kulekana, 9/30).

1 Oct 2009

Latest optical and laser technology in medicine displayed at FiO meeting

From scopes that help premature babies breathe to techniques for imaging live neurons and beating hearts as they develop, the latest optical and laser technology being deployed in medicine and the biosciences will be on display at the Optical Society's (OSA) Annual Meeting, Frontiers in Optics (FiO), which takes place Oct. 11-15 at the Fairmont San Jose Hotel and the Sainte Claire Hotel in San Jose, Calif.

1 Oct 2009

New technique developed to kill swine flu in any indoor environment

The swine flu has started to spread across the US and there is one company ready to stop it in its tracks. Premier Ozone of Charlotte, NC has developed a proprietary system to kill swine flu in any indoor environment and eliminate bacteria and mold in the process. The specialized system uses no chemicals and has been proven to kill over 99.99% of all surface and airborne viruses and bacteria. The process has no adverse effects on buildings or furniture and is not dangerous to the public.

1 Oct 2009

PSA test vital for assessing prostate cancer

When it comes to the prostate cancer, the disease known as the "silent killer" because it often exhibits no symptoms, to be forewarned is to be forearmed. It is the second leading cancer killer in men, just behind lung cancer. Every year, more than 218,000 men are diagnosed with prostate cancer in the United States, claiming about 28,000 lives.

1 Oct 2009

Update from BioCryst Pharmaceuticals regarding intravenous peramivir

BioCryst Pharmaceuticals, Inc. today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA). BioCryst management intends to provide an update once the RFP process has reached a conclusion.

1 Oct 2009

Can-Fite BioPharma commences preparatory work for a Phase III trial with CF101 to treat Psoriasis

Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety

1 Oct 2009

Study reveals how kidney repair processes are controlled

A study by Monash University researchers has shed new light on the microscopic antennas in the kidney that are involved in the organ's repair process.

1 Oct 2009

Swemed Sense oocyte aspiration needle available now for Australian customers

“Swemed Sense, with its unique characteristics, is an important part of our existing product portfolio in Europe, and is now available even to our Australian customers, Says Vitrolife's Vice President of Marketing and Sales, Nils Sellbom. Vitrolife have identified Australia as one of the key markets in the world and we have a office located in Melbourne. Approximately 67 000 fertility treatment cycles are conducted in Australia and New Zealand each year”

1 Oct 2009

Welichem announces filing of clinical trial application with Health Canada

Welichem Biotech Inc. (the "Company") announces the filing with Health Canada of a clinical trial application for its lead, anti-inflammatory drug WBI-1001. The application is for a 3-month, double blinded clinical trial in patients with chronic atopic dermatitis at three trial centres.

1 Oct 2009

Federal employees can expect a big increase in their health care costs

Federal employees can expect big increases in their health-care costs in 2010, according to an announcement Tuesday. The Washington Post reports: "Employees enrolled in the Federal Employees Health Benefits Program will pay an average 8.8 percent more in health-care costs, according to figures released by the Office of Personnel Management.

1 Oct 2009

Amerinet, OKAAP sign five-year purchasing agreement

Amerinet, Inc., a leading national healthcare group purchasing organization, today announced a new five-year purchasing agreement with the Oklahoma Chapter of the American Academy of Pediatrics (OKAAP).

1 Oct 2009

Scientists report new development for diagnosing malignant melanoma

Scientists in Australia are reporting development and testing in laboratory animals of a potential new material for diagnosing malignant melanoma, the most serious form of skin cancer. Their study is scheduled for the September 10 issue of the ACS' Journal of the Medicinal Chemistry, a bi-weekly publication.

1 Oct 2009

Respiragene test for lung cancer motivates smokers to quit smoking

Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

1 Oct 2009

BMJ examines new strategy for universal healthcare in Asia Pacific

A BMJ News article examines a new strategy, which was released at the 60th session of WHO's regional committee for the Western Pacific, calling for countries in the Asia Pacific region to "strive for universal access to health care."

1 Oct 2009

Trichodesmium has important role in nitrogen cycle and carbon sequestration

A new study of microscopic marine microbes, called phytoplankton, by researchers at Woods Hole Oceanographic Institution (WHOI) and the University of South Carolina has solved a ten-year-old mystery about the source of an essential nutrient in the ocean.

1 Oct 2009

Less than half of men and women in Ontario with depression visit doctor for treatment

Less than half of men and women in Ontario who may be suffering from depression see a doctor to treat their potentially debilitating condition, according to a new women's health study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES).

1 Oct 2009

IDC to supply DR systems for Indian hospitals

IDC (Imaging Dynamics Company Ltd.) (TSX: IDL), announced it was awarded three separate contracts in June 2009 with hospitals in India to supply its high end X-Series 1590 digital radiography (DR) systems and Magellan software following an extensive process in which the IDC CCD-based DR technology was determined to provide the best combination of value and clinical performance.

1 Oct 2009

National Institutes of Health awards $16.8 million grant to Hutchinson Center/UW group

The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a $16.8 million, seven-year grant to launch a bicoastal research partnership between Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium and Children's Hospital of Philadelphia.

30 Sep 2009